Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05906745 · ClinicalTrials.gov registry record

Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.

A clinical trial of Heart Failure, sponsored by Tricog Health.

Completed
Registry status
52
Enrollment target
4
Study locations

NCT05906745: Completed study of Heart Failure, sponsored by Tricog Health.

NCT05906745 is a study of Heart Failure that has completed, run by Tricog Health. The registered enrollment target is 52 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05906745, a study of Heart Failure, has completed, sponsored by Tricog Health.

COMPLETED
Registry status
52 participants
Enrollment target
4
Study locations

Study Summary

A multicenter, non-randomized prospective longitudinal study to evaluate the feasibility of Tricog's Remote platform for Guideline Directed Medical Therapy (GDMT) titration and remote patient monitoring among patients with Heart Failure.

Conditions Studied

Study Locations (4)

Karnataka

  • Manipal Hospital - Bengaluru
  • Sakra World Hospital - Bengaluru

North Carolina

  • Duke University Medical Center - Durham

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2023-07-21
Est. Completion 2024-09-27

Sponsor

Tricog Health

1 total trials

What the Registry Record Tells You About NCT05906745

The ClinicalTrials.gov registry entry for NCT05906745 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is Tricog Health, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT05906745 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Karnataka, North Carolina, Texas.

Frequently Asked Questions

What is clinical trial NCT05906745 about?

NCT05906745 is a clinical study titled "Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.". A multicenter, non-randomized prospective longitudinal study to evaluate the feasibility of Tricog's Remote platform for Guideline Directed Medical Therapy (GDMT) titration and remote patient monitoring among patients with Heart Failure.

What is the current status of trial NCT05906745?

This trial is currently completed. The enrollment target is 52 participants. The study started on 2023-07-21. Estimated completion is 2024-09-27.

What conditions does trial NCT05906745 study?

This clinical trial studies the following conditions: Heart Failure.

Who is sponsoring clinical trial NCT05906745?

This trial is sponsored by Tricog Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05906745 being conducted?

This trial has 4 study locations across North Carolina, Texas, Karnataka. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.